Lx Medical Corporation is categorized under Research and Development Laboratories in Westwood, MA and active since 2011.
Lx Medical Corporation was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Andrei Vertikov at the company’s single location by writing to 315 Oak St, Westwood, Massachusetts MA 02090 or by phoning (781) 762-2569. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lx Medical Corporation |
| Contact Person: | Andrei Vertikov |
| Address: | 315 Oak St, Westwood, Massachusetts 02090 |
| Phone Number: | (781) 762-2569 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Lx Medical Corporation was started in 2011 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Andrei Vertikov for inquiries that concern Lx Medical Corporation by calling the company number (781) 762-2569, as your correspondence is most welcome. Additionally, the physical location of the single location of Lx Medical Corporation can be found at the coordinates 42.195475,-71.231044 as well as the street address 315 Oak St in Westwood, Massachusetts 02090.
For its online presence, you may visit Lx Medical Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.